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Background: Paediatric chronic fatigue syndrome or myalgic encephalopathy
(CFS/ME) is relatively common and disabling. Current guidance recommends referral
to specialist services, although some general practitioners believe the label of CFS/ME
is harmful and many are not confident about diagnosing CFS/ME. Aim: Explore
whether or not adolescents and their mothers value referral to a specialist service for
young people with CFS/ME. Methods: A qualitative study nested within a feasibility
study of interventions for CFS/ME [Specialist Medical Intervention and Lightning
Evaluation (SMILE)]. In-depth interviews were undertaken with 13 mothers and
12 adolescents participating in the SMILE study. Transcripts were systematically
assigned codes using the qualitative data organisation package NVivo and analysed
thematically using techniques of constant comparison. Results: Gaining access to the
specialist service was difficult and took a long time. Mothers felt that they needed to be
proactive and persistent, partly because of a lack of knowledge in primary and secondary
care. Having gained access, mothers felt the CFS/ME service was useful because it
recognised and acknowledged their child’s condition and opened channels of dialogue
between health-care professionals and education providers. Adolescents reported that
specialist medical care resulted in better symptom management, although some ado-
lescents did not like the fact that the treatment approach limited activity. Conclusions:
Adolescents and their mothers value receiving a diagnosis from a specialist service and
making progress in managing CFS/ME. General practitioners should support adolescents
with CFS/ME in accessing CFS/ME specialist services, consistent with current guidance.
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Introduction
Chronic fatigue syndrome or myalgic encephalo-
pathy (CFS/ME) is a chronic disabling illness of
uncertain aetiology (Royal College of Paediatrics
and Child Health, 2004). It is likely to be a
complex and multifactorial disorder (Afari and
Buchwald, 2003) characterised by debilitating
fatigue that is unlike everyday fatigue and can be
triggered by minimal activity (NICE, 2007). It is
characterised by a range of symptoms including
fatigue, malaise, headache, sleep disturbances and
difficulty in concentration as well as muscle pain,
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which fluctuate in intensity and severity (NICE,
2007). The estimated prevalence of CFS/ME in
young people aged 5–19 years varies between
0.05% and 2.34% depending on the definition and
diagnostic criteria used (Dobbins et al., 1997;
Jordan et al., 2000; Chalder et al., 2003; Farmer
et al., 2004; Jones et al., 2004; Rimes et al., 2007;
Nijhof et al., 2011). Most GPs will have on average
one to three adolescents with CFS/ME on their
patient lists (Office for National Statistics, 2011).
CFS/ME has a negative impact on quality of life
and on school attendance, affecting social and
emotional development in adolescence (Carter
et al., 1999; Bell et al., 2001; van Middendorp et al.,
2001; Crawley et al., 2009; Bould et al., 2011). One
per cent of secondary school adolescents miss one
day a week of school with CFS/ME (Crawley et al.,
2011). Guidelines from the National Institute of
Health and Clinical Excellence (NICE, 2007)
recommend that adolescents with CFS/ME are
offered access to specialist services immediately if
severely affected, within three months if moderately
affected and within six months if mildly affected.
Despite this, the median time from symptom
onset to being seen by a specialist service is still
18 months (Crawley and Sterne, 2009). Literature
suggests that there is resistance from primary care
practitioners to ‘label’ an adult with a diagnosis of
CFS/ME, and a more general lack of confidence in
labelling clear clinical features of CFS/ME (Bowen
et al., 2005). Webb et al. (2011) suggest that GPs
would have similar uncertainty when diagnosing
and managing adolescents, and concludes that GPs
and paediatricians need to be aware of local care
pathways and support families accessing NHS ser-
vices. The aim of this study was to understand the
experiences of adolescents and families in accessing
and using a specialist service, and explore whether
or not they value referral to a specialist service for
young people with CFS/ME.
Methods
Study group
We recruited participants from the Specialist
Medical Intervention and Lightning Evaluation
(SMILE) study designed to test the feasibility and
acceptability of recruiting adolescents to a rando-
mised controlled trial (RCT) comparing specialist
medical care with specialist medical care and the
Lightning Process. Further information about the
SMILE study can be found at: http://www.bristol.
ac.uk/ccah/research/childrencomplexhealthneeds/
chronic-fatigue/smile.html. Adolescents referred to
a large regional specialist CFS/ME service in South
West England were assessed by specialist clinicians
at their first appointment for study eligibility.
Participants were eligible for the SMILE study if
they had been diagnosed with CFS/ME, were aged
between 12 and 18 years and were mildly or mod-
erately affected by the condition; that is, they were
not house bound (NICE, 2007). Clinicians informed
eligible participants about the SMILE study and
interested participants were visited at home a few
days later by a research officer to discuss the study
in more detail and to be randomised to either
intervention if willing. In-depth qualitative inter-
views were undertaken with adolescents and their
mothers who had agreed to participate in the
SMILE study to determine their views on the
specialist service, study participation and the inter-
ventions received.
Sampling, data collection and analysis
We purposively sampled those participating in
the SMILE study to ensure that interviews included
a range of participants in terms of age, sex, socio-
economic circumstance and ethnicity as well as
families from both intervention arms (maximum
variation sampling), with the potential to target
participants with characteristics of interest to
follow-up and develop emerging findings (theoretical
sampling). Families were interviewed at three
possible time points: after initial assessment at the
specialist clinic and before randomisation, after
randomisation but before the intervention, and
after the intervention. Adolescents with CFS/ME
were interviewed once at one of these time points
for not more than 20min.
Parent interviews lasted for 20–60min and
were conducted at a convenient location, usually
at the participants’ homes. A checklist of topics
was used to ensure that similar areas were covered
in each interview but with sufficient flexibility to
enable participants to raise topics of interest to
them. The guide covered questions concerning
experiences of the initial clinical assessment
appointment, study participation and the interven-
tions that young people received (see Appendix for
checklist of topics).
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Interviews were audio-recorded and transcribed
verbatim. Data items were systematically assigned
codes using the qualitative data organisation
package NVivo (QSR International Pty Ltd, 2010)
and analysed thematically using techniques of
constant comparison (Glaser and Strauss, 1967).
The constant comparative approach enabled
early data analysis, and this led to the addition of
two prompts on the interview schedule. One
prompt initiated discussion about ‘how families
got to the CFS/ME service’ if mothers had not
already discussed this, but the majority of
mothers initiated discussion about this topic.
Perspectives of participants were of paramount
importance, with careful account taken of the
context within which the discussion took place.
Data analysis was an ongoing and iterative pro-
cess, commencing soon after data collection star-
ted and informing further sampling and data
collection. Two members of the research team
analysed ,10% of the data independently to
compare coding and enhance its reliability. Des-
criptive accounts were produced, and theoretical




Thirteen mothers were approached and all
were interviewed. Five mothers were interviewed
at all three time points to form case studies. The
remaining eight mothers took part in one-off
interviews: four post randomisation and four after
their child received an intervention. Fifteen ado-
lescents were approached to be interviewed. One
mother did not consent to her child being inter-
viewed, and two adolescents (a 16-year-old boy
and a 14-year-old girl) declined. Of the 12 ado-
lescents, five were interviewed post randomisa-
tion but before receiving the intervention, and
seven after the intervention. Three adolescents
were male and nine were female.
Table 1 shows baseline characteristics of the
adolescents interviewed and those seen by the
service during the same time period. The mean
age of interviewed adolescents was 13.9 years;
75% were female and the median illness duration
was 13 months. Those interviewed were similar to
those who were diagnosed at the specialist clinic,
except that they were slightly younger (mean age
13.9 compared with 14.8 years, P5 0.07).
Thematic analysis
Thematic analysis was performed using quotes
about specialist medical care from mothers and
adolescents. All mothers and adolescents acces-
sed specialist medical care and all commented on
the care received. All mothers and some adoles-
cents commented on their journey before the
assessment.
Three themes were identified around parent
and adolescent experiences of accessing a specialist
service:
1. Long and difficult journey to the CFS/ME service.
2. Recognition and progress, taking the next steps.
3. Dialogue opened between health-care profes-
sionals and education providers.
Long and difficult journey to the
CFS/ME service
Nearly all mothers reported a period of pro-
longed illness, and most described a long and
difficult journey to the CFS/ME service. Mothers
felt that there was a lack of initial guidance
or information around CFS/ME and day-to-day
Table 1 Comparison of characteristics of adolescents aged 12–18 years diagnosed with CFS/ME
by the paediatric CFS/ME service between 01/09/2010 and 31/12/2011, with the sample of
adolescents interviewed for qualitative analysis
Interviewed (n5 12) CFS cohort (n5129) P-valuea
Female (%) 9 (75.0%) 103 (79.8%) 0.71
Age (years), mean (SD) 13.9 (1.6) 14.8 (1.6) 0.07
Illness duration, median (IQR) 13 (9 to 18) 12 (8 to 24) 0.99
CFS/ME5 chronic fatigue syndrome/Myalgic Encephalopathy.
a Fisher’s exact test for comparison of proportions, Student’s t-test for comparison of mean
values, Mann–Whitney two-sample test for comparison of medians.
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management of symptoms before accessing the
specialist service, leading to initial confusion and
uncertainty about their child’s health and possible
diagnosis of CFS/ME:
‘I feel as though it’s in the later stages, I can
see the light at the end of the tunnel now, I
couldn’t see that 2 years agoywe weren’t
even given a form [giving information about
CFS/ME] when [young person, YP8] was
first diagnosed. Not even a piece of paper. It
was disgusting’
(Mother of YP8: female aged 16 years)
‘because at the beginning you’re just going
out of your mind because you don’t know
what’s wrong with your child, and because
extreme tiredness can be a symptom of any
number of different illnesses, you really feel
completely at sea’
(Mother of YP2: female aged 14 years)
Before accessing the specialist CFS/ME service,
there was also confusion around diagnosis, which
was either uncertain or given as CFS/ME but with
a lack of conviction:
‘[paediatrician said] we’ll see if all the blood
tests are clear, which they were, so they said
yeah, you’ve definitely, probably got ME’
(Mother of YP7: male aged 13 years)
‘at the [hospital] they did lumbar punctures
and a brain scan just to rule out anything
nasty and it was actually myself that
suggested to them that perhaps it was an
ME type of condition’
(Mother of YP12: female aged 15 years)
The journey to the CFS/ME service was
deemed complex and frustrating with numerous
interactions with health-care professionals at
various locations, and long periods of waiting
intensified by repeated blood tests to rule out
serious acute illnesses:
‘It took ages, it took absolutely agesyshe
had lots and lots of blood tests and things,
and then we had to wait for them to come
back, then she had to have some more tests
yits good they’ve eliminated some, some
nasty illnesses but then you’re no further for-
ward in understanding what it’s all about’
(Mother of YP2: female aged 14 years)
A small number of mothers reported having to
wait for funding to be agreed before their child
could access the specialist CFS/ME service.
Co-morbid conditions further complicated the
journey to the CFS/ME service by introducing
complexity to the process of diagnosis or masking
CFS/ME symptoms and hindering symptom
management. Nearly all mothers suggested that
other conditions, such as behavioural issues or
depression, had developed because of prolonged
illness with CFS/ME:
‘looking back YP12 had like awful behaviour
which was really upsetting as a parent, really
aggressive and nasty, which she was at times,
which I think was all to do with her illness’
(Mother of YP12: female aged 15 years)
Mothers felt that they had to be proactive and
persistent, using additional knowledge sources to
bypass potential gatekeepers who acted as a bar-
rier because of a lack of knowledge about either
CFS/ME, potential treatment or availability of
specialist services. This was felt to be the case for
both GPs and paediatricians:
‘I had to go back to the GP and say could
you refer us to this clinic that’s being orga-
nised? and he said ‘‘I’m quite happy to refer
you, but I have to say it doesn’t help
everybody’’yand I was cross because I
thought, so you knew about this clinic and
he hadn’t said ‘‘Right, this is what we’ll
do’’ywe were not referred straight away
and I think that comes back to the GPs;
I think at GP level there’s still either
ignorance or doubt’
(Mother of YP34: male aged 15 years)
‘I asked [paediatrician] could she be seen
by somebody from the CFS/ME service
because I’ve heard they do a lot more
research and he said to me, that ‘‘they do
nothing that I don’t do’’ythat was his exact
wordsyand it was then that we decided,
right, no YP8 needs to see somebody else’
(Mother of YP8: female aged 16 years)
Recognition and progress – taking the next steps
The majority of mothers reported the initial
assessment appointment with the CFS/ME service
as a positive experience, which was useful and
helpful. The service recognised and acknowledged
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the young person’s condition, resulting in a sense
of relief and reassurance. Mothers felt that symp-
toms were now being understood and they would
receive help:
‘and it was a big, such a relief when he got
there [CFS/ME service] yjust to sort of
have someone saying ‘‘Yes, this is what
you’ve got’’ and this is what you can do’
(Mother of YP34: male aged 15 years)
Referral to a specialist service gave families
access to an informative team of experts, for some
a formal diagnosis, and for all a tailored, patient-
centred specialist medical intervention that had
not been available earlier. This enabled positive
change and steps towards a managed recovery:
‘it was absolutely amazing, she [CFS/ME
service clinician] knew exactly what she was
talking about and I didn’t feel that [paedia-
trician] didy.in fact I found with a lot of the
doctors that we’ve seen, to be honest with
you, not all of them accept it [CFS/ME]’
(Mother of YP8: female aged 16 years)
‘I think it was really empowering for us to feel
we had a form to follow, we had a technique
to apply and that really, really helped’
(Mother of YP36: female aged 13 years)
‘I found this concrete information that
we’ve got from our appointment much,
much better’
(Mother of YP4: male aged 12 years)
Some mothers felt that the CFS/ME service
reinforced symptom management strategies that
they had been trying to get their child to follow,
and that they felt their child would be more likely
to listen if techniques were legitimised by a
health-care professional:
‘although she does listen to her mum, they
don’t at her age it’s better coming from a
professional, or better to be reinforced by a
professional, because it just comes across as
mum nagging’
(Mother of YP88: female aged 17 years)
Half the adolescents reported that specialist
medical care was positive, as it enabled them to
talk about their illness (as opposed to continuing
with investigative tests and procedures) and gave
guidance on how to manage their condition.
This brought structure and a sense of normality
back into their lives:
‘I thought they [CFS/ME service] were quite
helpful; I think just to talk about things it is
really good’
(YP12: female aged 15 years)
‘I think it’s [specialist medical care] really
good and it’s really useful and helpful, and
you know what you can do yrather than
what you can’t doyso it’s quite good to
know that you can still do like normal stuff,
just not so much of it and it’s really good’
(YP2: female aged 14 years)
However, half reported that, although specialist
medical care resulted in better symptom man-
agement, accepting that for a time they must
reduce activity levels and adopt a routine was
challenging:
‘YP34 didn’t take very kindly to the initial
suggestions of their course of treatment
ywhat he really resented was the sort of the
limited, going to bed, strict routine, getting
up and things’
(Mother of YP34: male aged 15 years)
A few mothers also noted that specialist med-
ical care strategies had an impact on the whole
family and could be difficult to integrate with
their routine lifestyle:
‘The appointments are one thing, but going
home and implementing these things had a
huge impact on our lifestyle at home’
(Mother of YP36: female aged 13 years)
Dialogue opened between health-care
professionals and education providers
Mothers discussed the beneficial way in which
the CFS/ME service opened channels of dialogue
between health-care professionals and education
providers in a variety of ways. A letter provided
by the CFS/ME service confirming a diagnosis
enabled mothers to legitimately take their child
out of school, request funding for home schooling
and more generally inform and gain support from
teachers when managing reduced attendance:
‘the teachers at that point hadn’t been very
supportiveythey said YP12 was faking, that
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wasn’t the word used but you know it was
the body language and things like that you
could see that ‘‘oh another teenager trying it
on sort of thing’’, so it was really nice to get
supportythey did that for me, they actually
wrote to the school and explained’
(Mother of YP12: female aged 15 years)
Discussion
This study showed that, despite the largely posi-
tive experience of using a specialist service, the
journey to it was long and difficult, dependent
partially on whether professionals knew about the
service and treatment available. The specialist
service provided a firm diagnosis and treatment
plan, recognition of what was happening and
improved support from education providers;
however, some adolescents did not like the fact
that the treatment approach limited activity.
Strengths and weaknesses of the study
This is the first study to investigate both ado-
lescent and parent views on specialist CFS/ME
services. By using in-depth interviews, partici-
pants were able to convey complex accounts and
discuss issues that they felt to be important, pro-
viding a rich data set that may not have emerged
through more structured questionnaire-based
research. Parent/adolescent relations during a
chronic illness can be complex, with adolescents
challenging their parents as authority figures.
Interviewing mothers and adolescents enabled us
to capture some of this complexity.
The specialist paediatric CFS/ME service is a
well-established service in an area that covers
rural and urban populations. Although the service
accepts referrals from general practitioners, it
also accepts referrals from secondary care.
Patients accessing the specialist service may be
more severely affected or their condition may be
more complex than those seen in primary and
secondary care, and these results may not be
transferable to community or secondary care
services.
Those recruited to this study were part of a
feasibility RCT. Patients recruited to RCTs can
differ from those who are eligible but not
recruited to a trial (Rothwell, 2005), and therefore
these results may not be transferable to non-trial
participants. Adolescents who participated in the
SMILE study were mild-to-moderately affected by
CFS/ME, and therefore the experiences of young
people with severe CFS/ME and their families
might be different. However, the adolescents who
participated in this study were similar to the larger
clinic population, and characteristics of informants
have been given so that readers can judge trans-
ferability of findings to their own patient group.
In this study, only mothers consented to be
interviewed. This may be because mothers were
more likely to attend the initial assessment
appointment with their child (Missen et al., 2011)
or because mothers still take on more ‘caring’
responsibilities within the family, and either take
time off from work or work part time to attend
clinical or interview appointments.
Comparison with existing literature
Mothers had difficulty accessing the specialist
service, which they felt was because of lack of
knowledge from both GPs and paediatricians
about diagnosis or available treatment. This is
consistent with a report from ‘Action for ME’
(2008) where one in three adults and young
people said that their GP was either unsupportive
or less informed than they should be about
CFS/ME. Only 52% of GPs feel confident diag-
nosing CFS/ME in adults (Bowen et al., 2005), and
GPs may be less confident in diagnosing adoles-
cents. In addition, many GPs feel that the label of
CFS/ME can be harmful because it does not offer a
clear management pathway for patients, although
other GPs believe that the labelling effect is limited
and short-lived (Chew-Graham et al., 2010).
There is considerable debate about the value of
labels in adult fatigue syndromes (Hamilton et al.,
2005; Huibers and Wessely, 2006), with some
suggesting that using the label CFS/ME may lead
to pessimistic beliefs and a self-fulfilling prophecy,
triggering or validating perceptions of ill health
and perpetuating and exaggerating symptoms
(Huibers and Wessely, 2006). However, our study
suggests that, for adolescents, a label can be
helpful by shifting the illness from unknown to
known and stopping the repetition of ambiguous
tests and procedures, which can contribute to
an overall ‘difficult emotional experience’ for
adolescents with CFS/ME (Jelbert et al., 2010).
Confirmation by the medical profession and a
Adolescents and mothers value referral for CFS/ME 139
Primary Health Care Research & Development 2014; 15: 134–142
belief in mothers’ observations of their child’s ill
health also legitimises the struggle mothers have
experienced in pursuing access to services.
Mothers and young people in this study valued
the specialist service because it provided a way
forward in terms of treatment and improved
dialogue between professionals. NICE guidance
2007 makes clear recommendations for the diag-
noses and treatment of CFS/ME, including referral
to specialist services. Results of an ME Association
Survey (The ME Association, 2010) suggested that
patients and carers rated ‘a specialist CFS/ME
centre’ as their first choice when asked where they
would like to be treated. However, there are few
services for adolescents with CFS/ME, as high-
lighted by the all-party inquiry into NHS service
provision (2010), which suggested that this had led
to many not receiving adequate care.
Implications for practice and research
Adolescents and their mothers value receiving
a diagnosis from a specialist CFS/ME service and
making progress in managing their condition, but
access to such a service is a long and difficult
process. Primary care services should better sup-
port adolescents with CFS/ME in gaining access
to specialist health care and professional advice,
consistent with current NICE guidelines (NICE,
2007). Further research is needed to investigate
whether labelling in paediatric CFS/ME changes
outcome or engagement in specialist medical care.
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Appendix
Interview Topic Guide
*Questions used to elicit responses to accessing a
specialist CFS/ME service.
These questions will be used as prompts to ensure
all important areas are covered.
Welcome, introduction, discuss confidentiality &
consent, sign consent form. Check continues to be
happy with consent process.
After assessment & before randomisation
1. *Can you talk me through YP’s initial
appointment with the specialist?
Prompts: What was said, did you understand what
was being said? Feelings?
Additional prompt: How did [child] get to the
CFS/ME service?
2. *What were your initial thoughts about the
study?
Prompts: What did you think when you were told
about it? Feelings? Worries? Expectations?
3. What did you think about the information you
were given about the study?
Prompts: What information did you get – oral and
written (PIS)? Did you read it? Understand it?
Did it give you enough information/too much?
Were there things you thought they had forgotten
to include?
4. Did you know anything about the Lightning
Process before this initial appointment (for first
interview only)?
Prompts: How/ who? What did you think? What
information?
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5. Have you found out any information about the
Lightning Process since?
Prompts: Why? How? What did you find? What
did you think?
6. What are your thoughts at this stage on taking
part or not? Why?
NB – Stress that they’re not being asked at this stage
but that we want to gauge their thoughts, stress also
that it makes no difference to the interviewer
7. *If you were to take part, would you have a
preference for one of the interventions?
Prompts: Why? What would you do if allocated
the other intervention? Issues over participation?
Engagement?
8. What do you think about having treatments
allocated at random, i.e. by chance?
Prompts Why is it done? How do you feel about
this way of deciding what treatment you’ll get? Is
there a better way? Do you think you’ll be happy to
be randomised? Do you think you’re likely to get
one intervention rather than the other? Why?
9. *You have now done some questionnaires at
follow up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly difficult
ones? What did you think about the HADS/
POMS inventory? Would you leave some out?
Other areas that should be covered?
After randomisation & before interventions
1. Can you tell me what happened when the
research nurse visited and explained about ran-
domisation?
Prompts: What did she say? Understandable?
What did you think? Did you understand what
was going to happen?
2. What did you think before randomisation?
Prompts: Were you happy with the process?
Did you understand what was going to happen
and why?
3. Did you agree to randomisation or not? Why?
4. *What did you think when you got your inter-
vention allocation?
Prompts: How did you feel? Was it what you
expected/wanted? Expectations of intervention?
What have you done since then?
5. You have now done some questionnaires at
follow up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly difficult
ones? What did you think about HADS/ POMS
inventory? Would you leave some out? Other
areas that should be covered?
After intervention
1. *Tell me about the intervention you received?
Prompts: What happened? What was good/bad?
What would you change? Venue? Structure of
sessions? Language used? Was it as expected?
2. Do you think you/your child have/has learnt
anything from it, if so what?
Prompts: About CFS/ME, themselves, self man-
agement?
3. What has happened after the intervention?
Prompts: How have you/they done? What are
you/they doing? Feeling?
Additional prompt: How did LP fit with SMC?
How did you manage conflict [if reported by
participant]
4. What do you think now about being randomised?
Prompts: Would you do it again? What do you
think about the study for others?
5. You have now done some questionnaires at
follow up. What did you/your child think about
the questions you were asked?
Prompts: Were there any particularly any
difficult ones? What did you think about the
HADS/ POMS inventory? Would you leave some
out? Other areas that should be covered?
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